Publication: Finasteride and its potential for the treatment of female pattern hair loss: Evidence to date
Issued Date
2020-01-01
Resource Type
ISSN
11778881
Other identifier(s)
2-s2.0-85081032303
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Drug Design, Development and Therapy. Vol.14, (2020), 951-959
Suggested Citation
Wimolsiri Iamsumang, Kanchana Leerunyakul, Poonkiat Suchonwanit Finasteride and its potential for the treatment of female pattern hair loss: Evidence to date. Drug Design, Development and Therapy. Vol.14, (2020), 951-959. doi:10.2147/DDDT.S240615 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/53907
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Finasteride and its potential for the treatment of female pattern hair loss: Evidence to date
Other Contributor(s)
Abstract
© 2020 Iamsumang et al. The currently approved treatment for female pattern hair loss (FPHL) includes topical minoxidil administration; however, this treatment fails to achieve hair regrowth in some patients. Finasteride, a selective 5α-reductase inhibitor (5-ARI), may be considered as an alternative treatment. However, because of its potential teratogenic effects, clinical studies and use of finasteride for FPHL are limited. In this review, we aim to summarize the literature regarding the pharmacology, clinical efficacy, and adverse effects of oral finasteride for the treatment of FPHL and to provide novel therapeutic options including topical finasteride and dutasteride, a new generation 5-ARI, for the treatment of FPHL.